logo

输血设备市场 - 增长、趋势、COVID-19 影响和预测（2022 - 2027 年）

输血设备市场按产品、最终用户（医院、门诊手术中心、血库和其他最终用户）和地理位置进行细分。

Home Industry Reports Healthcare 输血设备市场 - 增长、趋势、COVID-19 影响和预测（2022 - 2027 年）

市场快照

Blood Transfusion Devices Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %
Blood Transfusion Devices Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

推动市场增长的某些因素是外科手术数量的增加、事故和创伤病例的增加、血液疾病的增加以及技术的发展。

最常见的需要输血的手术包括心血管手术、剖腹产手术以及外伤和意外伤害。根据 NIH 和国家心肺血液研究所的估计，输血在美国非常普遍，因为每年有超过 500 万美国人需要输血。大多数进行的手术都是为了心血管干预。此外，由于自然灾害和广泛的因果关系，全球对输血的需求正在增加。

贫血、白细胞减少、红细胞增多症、白细胞增多症和血小板增多症等血液疾病数量的增加也在推动输血市场。根据世界卫生组织的说法，大多数地中海贫血儿童出生在低收入国家，这些国家很难获得输血或只有一小部分人口可以获得输血。

报告范围

根据报告的范围，输血是一种收集血液和血液制品并通过静脉注射进入人体循环的过程。输血设备包括用于血液和血液制品的采集、处理、分离和保存的医疗设备。

By Product
Blood Bag and Accessory
Blood Mixer
Filter
Blood Component Separator
Apheresis Device
Pathogen Reduction System
Consumables and Supplies
Other Products
By End-user
Hospital
Ambulatory Surgical Centres
Blood Bank
Other End-users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

病原体减少系统有望见证健康成长

输血市场的病原体减少系统部分被认为在预测期内见证了健康的增长。随着具有成本效益和创新的灭活或降低感染风险的解决方案的出现，对病原体减少系统的需求正在增长。例如，Cerus Corporation 的 INTERCEPT 血液系统显着提高了全球 100 多个血液中心的血液安全性。

它主要用于治疗由白血病中白细胞计数升高引起的白细胞停滞。它还用于严重的类风湿性关节炎，以降低抗体介导的器官排斥反应、系统性狼疮、Goodpasture 综合征、多发性肌炎或皮肤真菌病以及妊娠期先兆子痫和子痫的风险。

Blood Transfusion Devices Market Trends

北美主导输血设备市场

北美目前主导着输血设备市场，预计未来将保持强劲，因为越来越多的创伤病例和外科手术推动了对输血的需求。美国占据了北美的大部分市场。根据美国国家红十字会的估计，美国每天需要大约 36,000 个单位的红细胞，每年输血近 2100 万份血液成分。这表明该国对输血的需求很高。这些统计数据也表明对输血产品的高需求。因此，确保这些产品的持续供应对于支持该地区不断增长的医疗保健需求至关重要。

Blood Transfusion Devices Market Growth

竞争格局

输血市场竞争适度，由几个主要参与者组成。然而，随着技术进步和产品创新，中小型公司正在通过推出具有成本效益的新产品来增加其市场占有率。Immucor Inc.、Becton Dickinson、B. Braun、Terumo Corporation 和 Grifols SA.等公司在输血市场占有重要份额。

"Immucor Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Terumo Corporation, Grifols SA"

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Surgical Procedures

      2. 4.2.2 Rise in the Number of Blood Disorders

      3. 4.2.3 Technological Advancements in the Devices

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Framework

      2. 4.3.2 High Costs Associated with Handling of Blood and its Components

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Blood Bag and Accessory

      2. 5.1.2 Blood Mixer

      3. 5.1.3 Filter

      4. 5.1.4 Blood Component Separator

      5. 5.1.5 Apheresis Device

      6. 5.1.6 Pathogen Reduction System

      7. 5.1.7 Consumables and Supplies

      8. 5.1.8 Other Products

    2. 5.2 By End-user

      1. 5.2.1 Hospital

      2. 5.2.2 Ambulatory Surgical Centres

      3. 5.2.3 Blood Bank

      4. 5.2.4 Other End-users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Immucor Inc.

      2. 6.1.2 Becton Dickinson

      3. 6.1.3 B. Braun Melsungen AG

      4. 6.1.4 Terumo Corporation

      5. 6.1.5 Grifols SA

      6. 6.1.6 Kaneka Corporation

      7. 6.1.7 Fresenius Kabi

      8. 6.1.8 Haemonetics Corporation

      9. 6.1.9 Macopharma SA

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Blood Transfusion Devices Market market is studied from 2018 - 2026.

The Blood Transfusion Devices Market is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Immucor Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Terumo Corporation, Grifols SA are the major companies operating in Blood Transfusion Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!